nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Infusion site reaction—Docetaxel—stomach cancer	0.0496	0.0496	CcSEcCtD
Oritavancin—Abscess—Floxuridine—stomach cancer	0.0412	0.0412	CcSEcCtD
Oritavancin—Extravasation—Mitomycin—stomach cancer	0.0293	0.0293	CcSEcCtD
Oritavancin—Bilirubin total increased—Epirubicin—stomach cancer	0.0258	0.0258	CcSEcCtD
Oritavancin—Bilirubin total increased—Doxorubicin—stomach cancer	0.0239	0.0239	CcSEcCtD
Oritavancin—Allergic cutaneous angiitis—Methotrexate—stomach cancer	0.0174	0.0174	CcSEcCtD
Oritavancin—Anaemia—Floxuridine—stomach cancer	0.0132	0.0132	CcSEcCtD
Oritavancin—Extravasation—Irinotecan—stomach cancer	0.0127	0.0127	CcSEcCtD
Oritavancin—Extravasation—Fluorouracil—stomach cancer	0.0122	0.0122	CcSEcCtD
Oritavancin—Blood bilirubin increased—Irinotecan—stomach cancer	0.0117	0.0117	CcSEcCtD
Oritavancin—Cellulitis—Fluorouracil—stomach cancer	0.0117	0.0117	CcSEcCtD
Oritavancin—Infection—Floxuridine—stomach cancer	0.0116	0.0116	CcSEcCtD
Oritavancin—Nervous system disorder—Floxuridine—stomach cancer	0.0114	0.0114	CcSEcCtD
Oritavancin—Leukocytoclastic vasculitis—Methotrexate—stomach cancer	0.0113	0.0113	CcSEcCtD
Oritavancin—Anaemia—Mitomycin—stomach cancer	0.0103	0.0103	CcSEcCtD
Oritavancin—Extravasation—Docetaxel—stomach cancer	0.0088	0.0088	CcSEcCtD
Oritavancin—Hypersensitivity—Floxuridine—stomach cancer	0.00857	0.00857	CcSEcCtD
Oritavancin—Cellulitis—Capecitabine—stomach cancer	0.00818	0.00818	CcSEcCtD
Oritavancin—Blood bilirubin increased—Docetaxel—stomach cancer	0.00812	0.00812	CcSEcCtD
Oritavancin—Diarrhoea—Floxuridine—stomach cancer	0.00796	0.00796	CcSEcCtD
Oritavancin—Blood bilirubin increased—Capecitabine—stomach cancer	0.00786	0.00786	CcSEcCtD
Oritavancin—Vomiting—Floxuridine—stomach cancer	0.00739	0.00739	CcSEcCtD
Oritavancin—Rash—Floxuridine—stomach cancer	0.00733	0.00733	CcSEcCtD
Oritavancin—Dermatitis—Floxuridine—stomach cancer	0.00733	0.00733	CcSEcCtD
Oritavancin—Headache—Floxuridine—stomach cancer	0.00729	0.00729	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.00726	0.00726	CcSEcCtD
Oritavancin—Abscess—Methotrexate—stomach cancer	0.007	0.007	CcSEcCtD
Oritavancin—Nausea—Floxuridine—stomach cancer	0.00691	0.00691	CcSEcCtD
Oritavancin—Eosinophilia—Fluorouracil—stomach cancer	0.00661	0.00661	CcSEcCtD
Oritavancin—Abscess—Epirubicin—stomach cancer	0.00655	0.00655	CcSEcCtD
Oritavancin—Extravasation—Methotrexate—stomach cancer	0.00634	0.00634	CcSEcCtD
Oritavancin—Diarrhoea—Mitomycin—stomach cancer	0.00624	0.00624	CcSEcCtD
Oritavancin—Abscess—Doxorubicin—stomach cancer	0.00606	0.00606	CcSEcCtD
Oritavancin—Dizziness—Mitomycin—stomach cancer	0.00604	0.00604	CcSEcCtD
Oritavancin—Hyperuricaemia—Methotrexate—stomach cancer	0.00597	0.00597	CcSEcCtD
Oritavancin—Infestation NOS—Fluorouracil—stomach cancer	0.00595	0.00595	CcSEcCtD
Oritavancin—Infestation—Fluorouracil—stomach cancer	0.00595	0.00595	CcSEcCtD
Oritavancin—Extravasation—Epirubicin—stomach cancer	0.00594	0.00594	CcSEcCtD
Oritavancin—Vomiting—Mitomycin—stomach cancer	0.0058	0.0058	CcSEcCtD
Oritavancin—Rash—Mitomycin—stomach cancer	0.00575	0.00575	CcSEcCtD
Oritavancin—Dermatitis—Mitomycin—stomach cancer	0.00575	0.00575	CcSEcCtD
Oritavancin—Headache—Mitomycin—stomach cancer	0.00572	0.00572	CcSEcCtD
Oritavancin—Cellulitis—Epirubicin—stomach cancer	0.0057	0.0057	CcSEcCtD
Oritavancin—Blood uric acid increased—Methotrexate—stomach cancer	0.00564	0.00564	CcSEcCtD
Oritavancin—Hyperuricaemia—Epirubicin—stomach cancer	0.00558	0.00558	CcSEcCtD
Oritavancin—Extravasation—Doxorubicin—stomach cancer	0.00549	0.00549	CcSEcCtD
Oritavancin—Connective tissue disorder—Irinotecan—stomach cancer	0.00548	0.00548	CcSEcCtD
Oritavancin—Blood bilirubin increased—Epirubicin—stomach cancer	0.00548	0.00548	CcSEcCtD
Oritavancin—Nausea—Mitomycin—stomach cancer	0.00542	0.00542	CcSEcCtD
Oritavancin—Blood uric acid increased—Epirubicin—stomach cancer	0.00527	0.00527	CcSEcCtD
Oritavancin—Cellulitis—Doxorubicin—stomach cancer	0.00527	0.00527	CcSEcCtD
Oritavancin—Cardiac disorder—Irinotecan—stomach cancer	0.00518	0.00518	CcSEcCtD
Oritavancin—Hyperuricaemia—Doxorubicin—stomach cancer	0.00517	0.00517	CcSEcCtD
Oritavancin—Blood bilirubin increased—Doxorubicin—stomach cancer	0.00507	0.00507	CcSEcCtD
Oritavancin—Immune system disorder—Irinotecan—stomach cancer	0.00504	0.00504	CcSEcCtD
Oritavancin—Mediastinal disorder—Irinotecan—stomach cancer	0.00503	0.00503	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.00502	0.00502	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.00492	0.00492	CcSEcCtD
Oritavancin—Blood uric acid increased—Doxorubicin—stomach cancer	0.00488	0.00488	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.00486	0.00486	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.00476	0.00476	CcSEcCtD
Oritavancin—Bronchospasm—Docetaxel—stomach cancer	0.00474	0.00474	CcSEcCtD
Oritavancin—Bronchospasm—Capecitabine—stomach cancer	0.00459	0.00459	CcSEcCtD
Oritavancin—Anaemia—Irinotecan—stomach cancer	0.00449	0.00449	CcSEcCtD
Oritavancin—Anaemia—Fluorouracil—stomach cancer	0.0043	0.0043	CcSEcCtD
Oritavancin—Infestation NOS—Docetaxel—stomach cancer	0.0043	0.0043	CcSEcCtD
Oritavancin—Infestation—Docetaxel—stomach cancer	0.0043	0.0043	CcSEcCtD
Oritavancin—Infestation NOS—Capecitabine—stomach cancer	0.00416	0.00416	CcSEcCtD
Oritavancin—Infestation—Capecitabine—stomach cancer	0.00416	0.00416	CcSEcCtD
Oritavancin—Myalgia—Fluorouracil—stomach cancer	0.00396	0.00396	CcSEcCtD
Oritavancin—Infection—Irinotecan—stomach cancer	0.00394	0.00394	CcSEcCtD
Oritavancin—Nervous system disorder—Irinotecan—stomach cancer	0.00389	0.00389	CcSEcCtD
Oritavancin—Hypoglycaemia—Epirubicin—stomach cancer	0.00385	0.00385	CcSEcCtD
Oritavancin—Oedema peripheral—Docetaxel—stomach cancer	0.0038	0.0038	CcSEcCtD
Oritavancin—Connective tissue disorder—Docetaxel—stomach cancer	0.00379	0.00379	CcSEcCtD
Oritavancin—Infection—Fluorouracil—stomach cancer	0.00377	0.00377	CcSEcCtD
Oritavancin—Nervous system disorder—Fluorouracil—stomach cancer	0.00372	0.00372	CcSEcCtD
Oritavancin—Tachycardia—Fluorouracil—stomach cancer	0.0037	0.0037	CcSEcCtD
Oritavancin—Oedema peripheral—Capecitabine—stomach cancer	0.00368	0.00368	CcSEcCtD
Oritavancin—Connective tissue disorder—Capecitabine—stomach cancer	0.00367	0.00367	CcSEcCtD
Oritavancin—Erythema multiforme—Docetaxel—stomach cancer	0.00365	0.00365	CcSEcCtD
Oritavancin—Cardiac disorder—Docetaxel—stomach cancer	0.00358	0.00358	CcSEcCtD
Oritavancin—Hypoglycaemia—Doxorubicin—stomach cancer	0.00356	0.00356	CcSEcCtD
Oritavancin—Erythema multiforme—Capecitabine—stomach cancer	0.00353	0.00353	CcSEcCtD
Oritavancin—Immune system disorder—Docetaxel—stomach cancer	0.00348	0.00348	CcSEcCtD
Oritavancin—Mediastinal disorder—Docetaxel—stomach cancer	0.00348	0.00348	CcSEcCtD
Oritavancin—Cardiac disorder—Capecitabine—stomach cancer	0.00347	0.00347	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00346	0.00346	CcSEcCtD
Oritavancin—Eosinophilia—Methotrexate—stomach cancer	0.00344	0.00344	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00342	0.00342	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.00339	0.00339	CcSEcCtD
Oritavancin—Immune system disorder—Capecitabine—stomach cancer	0.00337	0.00337	CcSEcCtD
Oritavancin—Mediastinal disorder—Capecitabine—stomach cancer	0.00337	0.00337	CcSEcCtD
Oritavancin—Malnutrition—Docetaxel—stomach cancer	0.00336	0.00336	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.00332	0.00332	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00328	0.00328	CcSEcCtD
Oritavancin—Malnutrition—Capecitabine—stomach cancer	0.00325	0.00325	CcSEcCtD
Oritavancin—Eosinophilia—Epirubicin—stomach cancer	0.00322	0.00322	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.00313	0.00313	CcSEcCtD
Oritavancin—Anaemia—Docetaxel—stomach cancer	0.0031	0.0031	CcSEcCtD
Oritavancin—Infestation—Methotrexate—stomach cancer	0.0031	0.0031	CcSEcCtD
Oritavancin—Infestation NOS—Methotrexate—stomach cancer	0.0031	0.0031	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.00307	0.00307	CcSEcCtD
Oritavancin—Urticaria—Fluorouracil—stomach cancer	0.00302	0.00302	CcSEcCtD
Oritavancin—Anaemia—Capecitabine—stomach cancer	0.003	0.003	CcSEcCtD
Oritavancin—Eosinophilia—Doxorubicin—stomach cancer	0.00298	0.00298	CcSEcCtD
Oritavancin—Hypersensitivity—Irinotecan—stomach cancer	0.00292	0.00292	CcSEcCtD
Oritavancin—Infestation NOS—Epirubicin—stomach cancer	0.0029	0.0029	CcSEcCtD
Oritavancin—Infestation—Epirubicin—stomach cancer	0.0029	0.0029	CcSEcCtD
Oritavancin—Myalgia—Docetaxel—stomach cancer	0.00286	0.00286	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00284	0.00284	CcSEcCtD
Oritavancin—Hypersensitivity—Fluorouracil—stomach cancer	0.0028	0.0028	CcSEcCtD
Oritavancin—Myalgia—Capecitabine—stomach cancer	0.00277	0.00277	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00275	0.00275	CcSEcCtD
Oritavancin—Infection—Docetaxel—stomach cancer	0.00272	0.00272	CcSEcCtD
Oritavancin—Diarrhoea—Irinotecan—stomach cancer	0.00271	0.00271	CcSEcCtD
Oritavancin—Nervous system disorder—Docetaxel—stomach cancer	0.00269	0.00269	CcSEcCtD
Oritavancin—Pruritus—Fluorouracil—stomach cancer	0.00269	0.00269	CcSEcCtD
Oritavancin—Infestation NOS—Doxorubicin—stomach cancer	0.00268	0.00268	CcSEcCtD
Oritavancin—Infestation—Doxorubicin—stomach cancer	0.00268	0.00268	CcSEcCtD
Oritavancin—Tachycardia—Docetaxel—stomach cancer	0.00267	0.00267	CcSEcCtD
Oritavancin—Skin disorder—Docetaxel—stomach cancer	0.00266	0.00266	CcSEcCtD
Oritavancin—Infection—Capecitabine—stomach cancer	0.00264	0.00264	CcSEcCtD
Oritavancin—Erythema multiforme—Methotrexate—stomach cancer	0.00263	0.00263	CcSEcCtD
Oritavancin—Dizziness—Irinotecan—stomach cancer	0.00262	0.00262	CcSEcCtD
Oritavancin—Nervous system disorder—Capecitabine—stomach cancer	0.0026	0.0026	CcSEcCtD
Oritavancin—Diarrhoea—Fluorouracil—stomach cancer	0.0026	0.0026	CcSEcCtD
Oritavancin—Tachycardia—Capecitabine—stomach cancer	0.00259	0.00259	CcSEcCtD
Oritavancin—Cardiac disorder—Methotrexate—stomach cancer	0.00258	0.00258	CcSEcCtD
Oritavancin—Skin disorder—Capecitabine—stomach cancer	0.00258	0.00258	CcSEcCtD
Oritavancin—Oedema peripheral—Epirubicin—stomach cancer	0.00256	0.00256	CcSEcCtD
Oritavancin—Connective tissue disorder—Epirubicin—stomach cancer	0.00256	0.00256	CcSEcCtD
Oritavancin—Vomiting—Irinotecan—stomach cancer	0.00252	0.00252	CcSEcCtD
Oritavancin—Immune system disorder—Methotrexate—stomach cancer	0.00251	0.00251	CcSEcCtD
Oritavancin—Dizziness—Fluorouracil—stomach cancer	0.00251	0.00251	CcSEcCtD
Oritavancin—Mediastinal disorder—Methotrexate—stomach cancer	0.00251	0.00251	CcSEcCtD
Oritavancin—Rash—Irinotecan—stomach cancer	0.0025	0.0025	CcSEcCtD
Oritavancin—Dermatitis—Irinotecan—stomach cancer	0.0025	0.0025	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.0025	0.0025	CcSEcCtD
Oritavancin—Headache—Irinotecan—stomach cancer	0.00248	0.00248	CcSEcCtD
Oritavancin—Erythema multiforme—Epirubicin—stomach cancer	0.00246	0.00246	CcSEcCtD
Oritavancin—Malnutrition—Methotrexate—stomach cancer	0.00242	0.00242	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00242	0.00242	CcSEcCtD
Oritavancin—Cardiac disorder—Epirubicin—stomach cancer	0.00241	0.00241	CcSEcCtD
Oritavancin—Vomiting—Fluorouracil—stomach cancer	0.00241	0.00241	CcSEcCtD
Oritavancin—Rash—Fluorouracil—stomach cancer	0.00239	0.00239	CcSEcCtD
Oritavancin—Dermatitis—Fluorouracil—stomach cancer	0.00239	0.00239	CcSEcCtD
Oritavancin—Headache—Fluorouracil—stomach cancer	0.00238	0.00238	CcSEcCtD
Oritavancin—Oedema peripheral—Doxorubicin—stomach cancer	0.00237	0.00237	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00237	0.00237	CcSEcCtD
Oritavancin—Connective tissue disorder—Doxorubicin—stomach cancer	0.00237	0.00237	CcSEcCtD
Oritavancin—Nausea—Irinotecan—stomach cancer	0.00235	0.00235	CcSEcCtD
Oritavancin—Immune system disorder—Epirubicin—stomach cancer	0.00235	0.00235	CcSEcCtD
Oritavancin—Mediastinal disorder—Epirubicin—stomach cancer	0.00234	0.00234	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00229	0.00229	CcSEcCtD
Oritavancin—Erythema multiforme—Doxorubicin—stomach cancer	0.00228	0.00228	CcSEcCtD
Oritavancin—Malnutrition—Epirubicin—stomach cancer	0.00226	0.00226	CcSEcCtD
Oritavancin—Nausea—Fluorouracil—stomach cancer	0.00225	0.00225	CcSEcCtD
Oritavancin—Anaemia—Methotrexate—stomach cancer	0.00224	0.00224	CcSEcCtD
Oritavancin—Cardiac disorder—Doxorubicin—stomach cancer	0.00223	0.00223	CcSEcCtD
Oritavancin—Immune system disorder—Doxorubicin—stomach cancer	0.00217	0.00217	CcSEcCtD
Oritavancin—Mediastinal disorder—Doxorubicin—stomach cancer	0.00217	0.00217	CcSEcCtD
Oritavancin—Urticaria—Capecitabine—stomach cancer	0.00211	0.00211	CcSEcCtD
Oritavancin—Malnutrition—Doxorubicin—stomach cancer	0.0021	0.0021	CcSEcCtD
Oritavancin—Anaemia—Epirubicin—stomach cancer	0.00209	0.00209	CcSEcCtD
Oritavancin—Myalgia—Methotrexate—stomach cancer	0.00206	0.00206	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00205	0.00205	CcSEcCtD
Oritavancin—Hypersensitivity—Docetaxel—stomach cancer	0.00202	0.00202	CcSEcCtD
Oritavancin—Infection—Methotrexate—stomach cancer	0.00196	0.00196	CcSEcCtD
Oritavancin—Hypersensitivity—Capecitabine—stomach cancer	0.00195	0.00195	CcSEcCtD
Oritavancin—Pruritus—Docetaxel—stomach cancer	0.00194	0.00194	CcSEcCtD
Oritavancin—Nervous system disorder—Methotrexate—stomach cancer	0.00194	0.00194	CcSEcCtD
Oritavancin—Anaemia—Doxorubicin—stomach cancer	0.00194	0.00194	CcSEcCtD
Oritavancin—Myalgia—Epirubicin—stomach cancer	0.00193	0.00193	CcSEcCtD
Oritavancin—Skin disorder—Methotrexate—stomach cancer	0.00192	0.00192	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00191	0.00191	CcSEcCtD
Oritavancin—Pruritus—Capecitabine—stomach cancer	0.00188	0.00188	CcSEcCtD
Oritavancin—Diarrhoea—Docetaxel—stomach cancer	0.00187	0.00187	CcSEcCtD
Oritavancin—Infection—Epirubicin—stomach cancer	0.00184	0.00184	CcSEcCtD
Oritavancin—Diarrhoea—Capecitabine—stomach cancer	0.00182	0.00182	CcSEcCtD
Oritavancin—Nervous system disorder—Epirubicin—stomach cancer	0.00181	0.00181	CcSEcCtD
Oritavancin—Dizziness—Docetaxel—stomach cancer	0.00181	0.00181	CcSEcCtD
Oritavancin—Tachycardia—Epirubicin—stomach cancer	0.0018	0.0018	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.0018	0.0018	CcSEcCtD
Oritavancin—Skin disorder—Epirubicin—stomach cancer	0.0018	0.0018	CcSEcCtD
Oritavancin—Myalgia—Doxorubicin—stomach cancer	0.00178	0.00178	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00177	0.00177	CcSEcCtD
Oritavancin—Dizziness—Capecitabine—stomach cancer	0.00175	0.00175	CcSEcCtD
Oritavancin—Vomiting—Docetaxel—stomach cancer	0.00174	0.00174	CcSEcCtD
Oritavancin—Rash—Docetaxel—stomach cancer	0.00173	0.00173	CcSEcCtD
Oritavancin—Dermatitis—Docetaxel—stomach cancer	0.00173	0.00173	CcSEcCtD
Oritavancin—Headache—Docetaxel—stomach cancer	0.00172	0.00172	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.0017	0.0017	CcSEcCtD
Oritavancin—Infection—Doxorubicin—stomach cancer	0.0017	0.0017	CcSEcCtD
Oritavancin—Vomiting—Capecitabine—stomach cancer	0.00169	0.00169	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00168	0.00168	CcSEcCtD
Oritavancin—Nervous system disorder—Doxorubicin—stomach cancer	0.00168	0.00168	CcSEcCtD
Oritavancin—Rash—Capecitabine—stomach cancer	0.00167	0.00167	CcSEcCtD
Oritavancin—Dermatitis—Capecitabine—stomach cancer	0.00167	0.00167	CcSEcCtD
Oritavancin—Tachycardia—Doxorubicin—stomach cancer	0.00167	0.00167	CcSEcCtD
Oritavancin—Headache—Capecitabine—stomach cancer	0.00166	0.00166	CcSEcCtD
Oritavancin—Skin disorder—Doxorubicin—stomach cancer	0.00166	0.00166	CcSEcCtD
Oritavancin—Nausea—Docetaxel—stomach cancer	0.00163	0.00163	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.0016	0.0016	CcSEcCtD
Oritavancin—Nausea—Capecitabine—stomach cancer	0.00158	0.00158	CcSEcCtD
Oritavancin—Urticaria—Methotrexate—stomach cancer	0.00157	0.00157	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00156	0.00156	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00148	0.00148	CcSEcCtD
Oritavancin—Urticaria—Epirubicin—stomach cancer	0.00147	0.00147	CcSEcCtD
Oritavancin—Hypersensitivity—Methotrexate—stomach cancer	0.00145	0.00145	CcSEcCtD
Oritavancin—Pruritus—Methotrexate—stomach cancer	0.0014	0.0014	CcSEcCtD
Oritavancin—Hypersensitivity—Epirubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Oritavancin—Urticaria—Doxorubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Oritavancin—Diarrhoea—Methotrexate—stomach cancer	0.00135	0.00135	CcSEcCtD
Oritavancin—Pruritus—Epirubicin—stomach cancer	0.00131	0.00131	CcSEcCtD
Oritavancin—Dizziness—Methotrexate—stomach cancer	0.00131	0.00131	CcSEcCtD
Oritavancin—Diarrhoea—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Oritavancin—Hypersensitivity—Doxorubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Oritavancin—Vomiting—Methotrexate—stomach cancer	0.00126	0.00126	CcSEcCtD
Oritavancin—Rash—Methotrexate—stomach cancer	0.00125	0.00125	CcSEcCtD
Oritavancin—Dermatitis—Methotrexate—stomach cancer	0.00124	0.00124	CcSEcCtD
Oritavancin—Headache—Methotrexate—stomach cancer	0.00124	0.00124	CcSEcCtD
Oritavancin—Dizziness—Epirubicin—stomach cancer	0.00122	0.00122	CcSEcCtD
Oritavancin—Pruritus—Doxorubicin—stomach cancer	0.00121	0.00121	CcSEcCtD
Oritavancin—Vomiting—Epirubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Oritavancin—Nausea—Methotrexate—stomach cancer	0.00117	0.00117	CcSEcCtD
Oritavancin—Diarrhoea—Doxorubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Oritavancin—Rash—Epirubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Oritavancin—Dermatitis—Epirubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Oritavancin—Headache—Epirubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Oritavancin—Dizziness—Doxorubicin—stomach cancer	0.00113	0.00113	CcSEcCtD
Oritavancin—Nausea—Epirubicin—stomach cancer	0.0011	0.0011	CcSEcCtD
Oritavancin—Vomiting—Doxorubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Oritavancin—Rash—Doxorubicin—stomach cancer	0.00108	0.00108	CcSEcCtD
Oritavancin—Dermatitis—Doxorubicin—stomach cancer	0.00108	0.00108	CcSEcCtD
Oritavancin—Headache—Doxorubicin—stomach cancer	0.00107	0.00107	CcSEcCtD
Oritavancin—Nausea—Doxorubicin—stomach cancer	0.00102	0.00102	CcSEcCtD
